Analystreport

RXi Pharmaceuticals Corp (NASDAQ: RXII) was given a new $3.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

RXI PHARMACEUTICALS CORP  (RXII) 
Last rxi pharmaceuticals corp earnings: 11/14 07:10 am Check Earnings Report
US:NASDAQ Investor Relations: investors.rxipharma.com